List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 320 studies with search of: breast cancer AND new jersey
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Recruiting Phase I/II Study of Weekly Abraxane and RAD001 in Women With Locally Adv. or Metastatic Breast Ca
Condition: Breast Cancer
Interventions: Drug: everolimus;   Drug: abraxane
2 Recruiting Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer
Conditions: Inflammatory Breast Cancer;   Invasive Ductal Breast Carcinoma;   Invasive Lobular Breast Carcinoma;   Mucinous Ductal Breast Carcinoma;   Papillary Ductal Breast Carcinoma;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer;   Tubular Ductal Breast Carcinoma
Intervention: Radiation: External beam radiation therapy
3 Active, not recruiting Capecitabine (Xeloda) and Lapatinib (Tykerb) as First-line Therapy in HER2/Neu-positive Breast Cancer
Conditions: Breast Cancer;   Metastatic Breast Cancer;   Advanced Breast Cancer;   HER2/Neu-positive Breast Cancer
Interventions: Drug: Capecitabine;   Drug: Lapatinib
4 Recruiting Radiation Therapy in Treating Women With Early Stage Breast Cancer
Condition: Breast Cancer
Interventions: Radiation: External beam boost;   Radiation: whole breast irradiation
5 Recruiting Internal Radiation Therapy of the Breast in Treating Women With Early-Stage Breast Cancer
Condition: Breast Cancer
Interventions: Radiation: accelerated partial breast irradiation;   Radiation: intracavitary balloon brachytherapy
6 Terminated Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast Cancer
Condition: Breast Cancer
Interventions: Biological: trastuzumab;   Drug: carboplatin;   Drug: docetaxel;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy
7 Active, not recruiting Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Previously Treated Locally Advanced or Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: imatinib mesylate
8 Terminated Ixabepilone and Hydroxychloroquine in Treating Patients With Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: hydroxychloroquine;   Drug: ixabepilone
9 Completed Studying Tumor Tissue Samples From Patients With Early-Stage Breast Cancer
Condition: Breast Cancer
Intervention:
10 Terminated Letrozole and Celecoxib in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: celecoxib;   Drug: letrozole
11 Completed Internet Use Among Women With Recurrent Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Other: medical chart review;   Other: questionnaire administration;   Other: survey administration;   Procedure: psychosocial assessment and care
12 Terminated Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer
Condition: Breast Cancer
Interventions: Drug: epirubicin hydrochloride;   Drug: vinorelbine ditartrate
13 Active, not recruiting Radiation Therapy Using Gold Markers in Treating Women With Early-Stage Breast Cancer
Condition: Breast Cancer
Intervention: Radiation: 3-dimensional conformal accelerated partial breast irradiation
14 Terminated Pazopanib in Treating Patients With Newly Diagnosed or Locally and/or Regionally Recurrent Breast Cancer That Can Be Removed By Surgery
Condition: Breast Cancer
Intervention: Drug: pazopanib hydrochloride
15 Terminated Treatment Decision Making Between Oncologists and Women With Newly Diagnosed Breast Cancer and Their Healthy Companions
Condition: Breast Cancer
Intervention:
16 Recruiting Phase II Trial of Doxil, Carboplatin, Bevacizumab in Triple Negative Untreated Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Interventions: Drug: Doxil;   Drug: Carboplatin;   Drug: Bevacizumab
17 Recruiting Phase I/II Trial of Letrozole and Sorafenib in Post-Menopausal Hormone-Receptor + Breast Cancer
Condition: Metastatic Breast Cancer
Interventions: Drug: Sorafenib;   Drug: Letrozole
18 Recruiting Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome
Conditions: Breast Cancer;   Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms;   Neuroblastoma;   Ovarian Cancer;   Testicular Germ Cell Tumor
Intervention: Dietary Supplement: Lactobacillus rhamnosus GG
19 Completed Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors
Conditions: Breast Cancer;   Colorectal Cancer;   Head and Neck Cancer;   Lung Cancer;   Melanoma (Skin);   Ovarian Cancer;   Pancreatic Cancer;   Prostate Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: bortezomib;   Drug: paclitaxel
20 Suspended ABT-888 and Cyclophosphamide With Versus Without Doxorubicin in Treating Patients With Metastatic or Unresectable Solid Tumors or Non-Hodgkin Lymphoma
Conditions: Breast Cancer;   Lymphoma;   Lymphoproliferative Disorder;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: veliparib

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services